Occurrence of Some Common Carbapenemase Genes in Carbapenem-Resistant Klebsiella Pneumoniae Isolates Collected From Clinical Samples in Tabriz, Northwestern Iran Publisher Pubmed



Jafarisales A¹ ; Alkhafaji NSK² ; Aldahmoshi HOM² ; Sadeghi Deylamdeh Z³ ; Akrami S^{4, 5} ; Shariat A¹ ; Judi HK⁶ ; Nasiri R⁷ ; Bannazadeh Baghi H⁸ ; Saki M⁵ Show Affiliations
Source: BMC Research Notes Published:2023

Abstract

Objectives: This study aimed to evaluate the antibiotic resistance patterns and prevalence of carbapenemase genes in Klebsiella pneumoniae isolates in different clinical samples from Tabriz city, northwestern Iran. Results: This cross-sectional study was conducted in the Department of Microbiology, Islamic Azad University, Ahar Branch, Iran, in 2020. K. pneumoniae isolates were collected from different clinical samples, including blood, wounds, sputum, and urine. The isolates were identified using a series of standard bacteriological tests. Antibiotic resistance was determined by the disc diffusion method. The presence of bla VIM, bla NDM, bla KPC, bla OXA, and bla IMP genes were screened by polymerase chain reaction (PCR). A total of 100 non-duplicated K. pneumoniae isolates were collected from 57 urine samples, 27 blood samples, 13 wound samples, and 3 sputum samples. Overall, 70.0% of the samples were from inpatients, while 30.0% were from outpatients. The most resistance rate was related to ampicillin (94.0%), while the lowest resistance rate was related to imipenem (18.0%) and meropenem (20.0%). Overall, 25.0% of the isolates were carbapenem-resistant, of which 13.0% were resistant to both imipenem and meropenem. The PCR showed the total prevalence of 23.0% for carbapenemase genes, including 18.0% for bla KPC, 3.0% for bla VIM, 1.0% for bla IMP, and 1.0% for bla OXA gene. The bla NDM gene was not detected in any isolate. The prevalence of carbapenemase-producing K. pneumoniae isolates was relatively lower in northwestern Iran than in other regions of the country. However, special attention should be paid to the proper use of antibiotics, particularly carbapenems, to prevent further spread of antibiotic resistance and its related genes. © 2023, The Author(s).